話題 : 癌症生物學與藥物研發研究所

2021.11.14 (W4) 13:00-15:00, Special lecture on processing & translational research of medical sciences
 - Systems Biology Applications in Metabolic Diseases @ 校本部 2204
2021.06.10 (W4) 10:00-12:00, Series Lecture on Drug Discovery and De velopment - Clinical trial execution @ https://meet.google.com/isd-nnty-zoo
2021.06.10 (W4) 10:00-12:00, Series Lecture on Drug Discovery and De velopment -  Biosimilar development and beyond @ https://meet.google.com/mid-ivuj-psw
2021.06.03 (W4) 10:00-12:00, Series Lecture on Drug Discovery and Development - Patent searching and application
2021.05.27 (W4) 13:00-15:00, Series Lecture on BioPharmaceutical - Clinical application and industrial development of cancer immunotherapy @ https://meet.google.com/gud-qaod-wcj
2021.05.27 (W4) 10:00-12:00, Series Lecture on Drug Discovery and Development - Drug marketing analysis @WEB
2021.05.06 (W4) 13:00-15:00,  Series Lecture on BioPharmaceutical - Clinical Trial in Development of Drugs / Medical Devices @Rear Building, 15F Conference Room 1
2021.05.06 (W4) 10:00-12:00, Series Lecture on Drug Discovery and Development - Preclinical study @Rear Building, 15F Conference Room 1
本研究由中研院院士龔行健帶領台北醫學大學及國家衛生研究院組成的團隊執行,研究論文已於今年4月23日刊登在全球知名醫學期刊「自然通訊」 (Nature Communications)
Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells